Evidence map›Paper›PMID 28472231›Full record

ArticleJAMA ophthalmology2017

Visual Impairment in Preschool Children in the United States: Demographic and Geographic Variations From 2015 to 2060.

Rohit Varma, Kristina Tarczy-Hornoch, Xuejuan Jiang

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JAMA ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Interventions for improving adherence to amblyopia treatments in children.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Article
  3. Causes of Reduced Vision in Australian Children.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vision impairment in boys recruited to the iREAD study.Israel journal of health policy research · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Prevalence of Myopia in Children in Spain: An Updated Study in 2020.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rohit VarmaRoski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles2Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Kristina Tarczy-HornochDepartment of Ophthalmology, University of Washington, Seattle4Seattle Children's Hospital, Seattle, Washington.
Xuejuan JiangRoski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles2Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
University of Southern California · USUniversity of Washington · US

Funding

The Pediatric Eye Disease Consortium: a Pooled Analysis of Individual-Participant Data from Population-based StudiesR21EY025313 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JIANG, XUEJUAN · 2015 to 2016
$484k
NEI NIH HHS R21 EY025313
6 · The paper itself

Abstract

Importance: Visual impairment (VI) in early childhood can significantly impair development. Objective: To determine demographic and geographic variations in VI in children aged 3 to 5 years in the United States in 2015 and to estimate projected prevalence through 2060. Design, Setting, and Participants: Descriptive study reporting statistics estimated based on prevalence data from 2 major population-based studies conducted in the United States between 2003 and 2011. Using US census projections, prevalence of VI and cause-specific VI in the better eye were reported by race/ethnicity, state and region, and per capita prevalence of VI by state. The study included preschool children in the United States. Analyses for this study were conducted between February 2016 and March 2017. Main Outcomes and Measures: Prevalence of VI among children aged 3 to 5 years in the United States. Results: In 2015, more than 174 000 children aged 3 to 5 years in the United States were visually impaired. Almost 121 000 of these cases (69%) arose from simple uncorrected refractive error, and 43 000 (25%) from bilateral amblyopia. By 2060, the number of children aged 3 to 5 years with VI is projected to increase by 26%. In 2015, Hispanic white children accounted for the highest number of VI cases (66 000); this group will remain the most affected through 2060, with an increasingly large proportion of cases (37.7% in 2015 and 43.6% in 2060). The racial/ethnic group with the second most VI is projected to shift from non-Hispanic white children (26.3% in 2015 decreasing to 16.5% in 2060) to African American children (24.5% in 2015 and 22.0% in 2060). From 2015 to 2060, the states projected to have the most children with VI are California (26 600 in 2015 and 38 000 in 2060), Texas (21 500 in 2015 and 29 100 in 2060), and Florida (10 900 in 2015 and 13 900 in 2060). Conclusions and Relevance: These data suggest that the number of preschool children with VI is projected to increase disproportionally, especially among minority populations. Vision screening for refractive error and related eye diseases may prevent a high proportion of preschool children from experiencing unnecessary VI and associated developmental delays.

Indexed as

EthnicityVisual AcuityChild, PreschoolCross-Sectional StudiesFemaleFollow-Up StudiesHumansMalePersons with Visual DisabilitiesPrevalenceRetrospective StudiesUnited StatesVision, LowVision Screening

Identifiers

PMID28472231
PMCPMC5710267
OpenAlexW2610303421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.